Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v2.4.0.6
Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Mar. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Series A
Jan. 14, 2013
Series A
Mar. 31, 2013
Series B
Jan. 14, 2013
Series B
Allowances for trade accounts receivable $ 30,198 $ 35,045        
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $ 96,421 $ 110,882        
Preferred Stock, Par or Stated Value Per Share $ 0.01          
Preferred Stock, Shares Authorized 50,000,000          
Preferred Stock, Shares Issued 0 0        
Preferred Stock, Shares Outstanding 0          
Common Stock, Par or Stated Value Per Share     $ 0.01   $ 0.01  
Common Stock, Shares Authorized     2,000,000,000   75,000,000  
Common Stock, Shares, Issued     111,903,059   9,882,238  
Common Stock, Shares, Outstanding     111,903,059 111,722,828 9,882,238 9,882,238